NueCura Partners, LLC Invests in RxREVU

NASHVILLE, Tenn., Apr. 22, 2015 /PRNewswire-iReach/ — NueCura Partners, LLC has added the rapidly growing Denver based start-up, RxREVU, to its portfolio. “We’re tremendously excited to partner with RxREVU. Their software represents an extraordinary new approach to prescribing, and will greatly assist doctors and patients in finding the right medication at the right price,” says Ted Sanft, Operating Partner at NueCura.

RxREVU helps consumers and providers find the best drugs available based on cost, condition, and clinical research. Their mission is to help people live happier and healthier lives by finding the most effective treatment at the lowest cost. The company is trail-blazing the use of predictive analytics to help analyze medications based on unique patient factors, such as age, gender and ethnicity.

“Working with NueCura Partners was a great experience all around. Their team brings a deep understanding of the healthcare industry and clearly understands the need for our technology,” said Carm Huntress, CEO of RxREVU, Inc. “We’ve met with many early stage investment groups and could not be more impressed with the partners’ backgrounds, connectivity to the Nashville healthcare community and support they’ve already given us as an early stage company” said Huntress.

NueCura Partners, LLC is a Nashville-based angel investment group that focuses on early-stage investment opportunities in the healthcare sector. NueCura is managed by seasoned healthcare business operators and leverages their experience to identify and finance breakthrough technologies in the healthcare space. You can learn more about RxREVU at www.rxrevu.com.

Media Contact: Susan Francisco, RxREVU, Inc., (800) 360-4965, susan.francisco@rxrevu.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE RxREVU

 

Meet Our Members: Ted Sanft

The following is an interview with Ted Sanft, and extraordinary Nashville business leader, healthcare innovator and investor. NueCura Partners is honored to count Ted amongst its membership!
Q: What is your motivation for angel investing?
A: I really have three reasons for pursuing angel investing:
1) In my past business experience, I have been primarily involved in venture capital and private equity investments and I wanted to learn more about angel investing.
2) I felt strongly that I wanted to help improve and grow the Nashville entrepreneurial ecosystem.
3) Hopefully I will find a great companies to help grow and monetize!

Q: What are the unique skills that you bring to the NueCura Partners group?
A: While I think I have a great understanding of business, at my core I am a technologist. I have the ability to understand how technology applies to the business, how sustainable that technology is, and how much technical risk is inherent in the potential company’s technology base. With my experience at Change Healthcare and Care Technology Systems, I also have a firm understanding of HIPAA and overall healthcare technology.

Q: What attracts you to the NueCura Partners model?
A: I really like the idea of this group of really smart folks reviewing deals. I am constantly surprised at the conclusions others draw when reviewing a company and the level of insight others provide in the deal reviews. Considering all the members opinions helps to make all of us smarter, more informed investors. The “deal flow” is also very attractive, we have already looked at a lot of companies and have invested in several. In my opinion, NueCura Partners brings a better approach to angel investing. It also helps immensely to have a practicing physician leading this group, since practical application of some of the products we are reviewing is best understood by someone that might use the product.

Q: What excites you about angel investing in healthcare in Nashville?
A: Everything! In all seriousness, the ecosystem for healthcare startups in Nashville is vibrant and there is a great deal of opportunity for the entrepreneur and the angel investor.

Overall, I think the NueCura Partners model can do great things for angel investing in Nashville and for the companies we invest in!

NueCura Partners, LLC: “Investing in the New Age of Healthcare”

We launched NueCura Partners, LLC with the goal of addressing an unmet need in the Nashville investment community.  There are many experienced business and healthcare operators who have an interest in investing in early-stage healthcare businesses, but don’t have the time, expertise or confidence to identify and evaluate good opportunities.  NueCura is attempting to change this paradigm.

Nashville is flush with traditional venture capital companies that offer excellent investment opportunities.  However, the typical VC model requires front and back end fees and the fund managers control all investment decisions. Alternatively, there are a few local angel investment companies but these also have fee requirements and are not healthcare specific.

NueCura Partner’s offers another option.  We are an affiliated angel investor model where each member makes their own investment decision following group and individual deal due diligence.  NueCura focuses specifically on investments in the healthcare sector.  We consider the full spectrum of healthcare-related businesses with the exception of biopharmaceuticals and implantable medical devices (beyond 510K approval).

NueCura Partners has taken capital positions in several well known offerings including Diatherix LaboratoriesNextGxDx, and LeanKit.  We are also participating in the upcoming Series A round financing for InvisionHeart.  The Nashville investment community has been very receptive to NueCura Partners and the professionalism and expertise we bring to the financing process for early-stage companies.  We are excited for our opportunity and for the potential we have to favorably impact new healthcare businesses in Nashville. We are investing in the ‘new age’ of healthcare!

NueCura: Proud Partner of Jumpstart Foundry

Jumpstart Foundry, a local Nashville business accelerator, was recently ranked in the top 15 of the countries best accelerators.  Companies were ranked based on the valuations of their portfolio companies achieved in the years after graduation.

NueCura Partners is a proud supporter of JSF.  We have invested in NextGxDx, JSF class of 2010 alumnus, and we are poised for our Series A Round investment in InvisionHeart from the graduating class of 2013.

Jumpstart Foundry is a 14-week, mentor-driven business acceleration program culminating in the launch of successful startups which are showcased at Investor Day. JSF has graduated over 30 companies since its inception in 2010 and has over 100 diverse business mentors participating in the program.  Vic Gatto, founder of JSF, says his goal is to place in the top five US business accelerators within the next few years.

As a representative of NueCura Partners, I have had the honor of participating as a Mentor for JSF and this year my involvement will also include being a member of the Selection Committee for the incoming class of 2014 as well as participating in the new Investor Mentor program.